Institut Dr. Schauerte
About Institut Dr. Schauerte
Institut Dr. Schauerte is a Healthcare company based in Munchen (Germany), and was acquired by Emmes in December 2021. Oncology and metabolism clinical trials are supported in phases II-IV. Its focus areas include Biopharma Outsourcing, CRO and Diversified. Its legal entity is Institut Dr. Schauerte GmbH.
Company details
Institut Dr. Schauerte is operated as a contract research organization in Munich, Germany. Clinical development services are delivered for oncology and metabolism therapeutic areas. Trials are managed across phases II, III, and IV to assist pharmaceutical clients. Operations are centered on regulatory compliance and data management within the European biotech sector. Expertise is applied to trial design, patient recruitment, and monitoring processes.
- Headquarters Munchen, Germany
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website dr-schauerte.de
- Acquired by Emmes (Dec 2021)
- Legal Name Institut Dr. Schauerte Gmbh
Investors in Institut Dr. Schauerte
Institut Dr. Schauerte has secured backing from 1 investor. Prominent investors backing the company include Emmes.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Outsourced contract research organization services are provided to clients. | 1977 | emmes.com | United States |
Investor details for Institut Dr. Schauerte
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Institut Dr. Schauerte
Complete news archive for Institut Dr. Schauerte
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Institut Dr. Schauerte
Institut Dr. Schauerte is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Institut Dr. Schauerte is operated as a contract research organization in Munich, Germany. Clinical development services are delivered for oncology and metabolism therapeutic areas. Trials are managed across phases II, III, and IV to assist pharmaceutical clients. Operations are centered on regulatory compliance and data management within the European biotech sector. Expertise is applied to trial design, patient recruitment, and monitoring processes.
Institut Dr. Schauerte has 1 investor. Key investors include Emmes.
Institut Dr. Schauerte operates through Institut Dr. Schauerte Gmbh.
Yes. Institut Dr. Schauerte was acquired by Emmes in December 2021.